Neurological complications of foam sclerotherapy: Fears and reality

Phlebology

Volumn 26, Issue 7, 2011, Pages 277-279

  Gillet, J L ^a  

^a Vascular Medicine and Phlebology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN;

CLINICAL ASSESSMENT; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; EDITORIAL; HUMAN; MIDDLE CEREBRAL ARTERY; NEUROLOGICAL COMPLICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PATENT FORAMEN OVALE; PRIORITY JOURNAL; SAPHENOUS VEIN; SCLEROTHERAPY; SPREADING CORTICAL DEPRESSION; TELANGIECTASIA;

CEREBROVASCULAR DISORDERS; DIFFUSION MAGNETIC RESONANCE IMAGING; EMBOLISM; FORAMEN OVALE, PATENT; HUMANS; MIDDLE CEREBRAL ARTERY; NERVOUS SYSTEM DISEASES; SAPHENOUS VEIN; SCLEROTHERAPY;

EID: 80053991849     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2011.011e04     Document Type: Editorial

References (34)

1. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-6
2. Morrison N, Neuhardt DL, Hansen K, Levin S, Salles-Cunha SX. Tracking foam to the heart and brain following ultrasound-guided sclerotherapy of lower extremity veins. Austral NZ J Phlebol 2007;10:6-9
3. Hansen K, Morrison N, Neuhardt D, Salles-Cunha SX. Transthoracic echocardiogram and transcranial doppler detection of emboli after foam sclerotherapy of leg veins. J Vasc Ultrasound 2007;31:213-6
4. Raymond-Martimbeau P. Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy. Phlebology 2009;24:114-9
5. Gibson KD, Regon JD, Shortell C, et al. Proprietory polidocanol endovenous microfoam bubble embolization does not cause cerebral injury. Phlebology 2009;24:85
6. Morrison N. Foam sclerotherapy: the challenge of neurological symptoms. UIP Abstracts Book 2009:73
7. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: Report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8
8. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Brit J Surg 2007;94:925-36
9. Gillet JL, Guedes JM, Guex JJ, et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;34:131-8
10. Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P. Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010;25:261-6
11. Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory [review]. Brain 1994;117:199-210
12. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002;125:102-12
13. Frullini A, Felice F, Burchielli S, Di Stefano R. High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 2011;26:203-8
14. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression migraine aura and patent foramen ovale. Ann Neurol 2010;67:221-9
15. Caputi L, Usai S, Carriero MR, et al. Microembolic air load during contrast-transcranial Doppler: a trigger for migraine with aura? Headache 2010;50:1320-7
16. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-4
17. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology 2008;23:189-92
18. Ma RWL, Pilotelle A, Paraskevas P, Parsi K. Three cases of stroke following peripheral venous interventions. Phlebology 2011;26:280-4
19. Leslie-Mazwi TM, Avery LL, Sims JR. Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care 2009;11:97-100
20. Hahn M, Schulz T, Jünger M. Late stroke after foam sclerotherapy. VASA 2010;39:108-10
21. Picard C, Deltombe B, Duru C, Godefroy O, Bugnicourt JM. Foam sclerotherapy: a possible cause of ischaemic stroke? J Neurol Neurosurg Psychiatry 2010;81:582-3
22. Hartmann K, Harms L, Simon M. Reversible neurological deficit after foam sclerotherapy. Eur J Vasc Endovasc Surg 2009;38:648-9
23. Delaney HC, Bowe CT, Higgins GL. Acute stroke from air embolism after sclerotherapy. West J Emerg Med 2010;11:397
24. Van der Plas JP, Lambers JC, Van Wersch JW, Koehler PJ. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 1994;43:428
25. Deichmann B, Blum G. Apoplektischer insult nach Sklerotherapie [in German]. Phlebologie 1995;24:148-52
26. Kas A, Begue M, Nifle C, Gil R, Neau JP. Cerebellar infarction after sclerotherapy for leg varicosities [in French]. Presse Med 2000;29:1935
27. Hanisch F, Muller T, Krivokuca M, Winterholler M. Stroke following variceal sclerotherapy. Eur J Med Res 2004;9:282-4
28. Harzheim M, Becher H, Klockgether T. Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr 2000;125:794-6
29. Caggiati A, Franceschini M. Stroke following endovenous laser treatment of varicose veins. J Vasc Surg 2010;51:218-20
30. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-6
31. Morrison N, Neuhardt DL, Rogers CR, et al. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity. Eur J Vasc Endovasc Surg 2010;40:407-13
32. Woods TD, Harmann L, Purath T, et al. Small-and moderate-size right-to-left shunts identified by saline contrast echocardiography are normal and unrelated to migraine headache. Chest 2010;138:264-9
33. Breu FX, Guggenbichler S, Wollmann JC, Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. VASA 2008;37:90-5
34. Morrison N, Neuhardt DL, Rogers C, McEown J, Vollis K. Studies on foam migration. Phlebology 2009;24:88